Every open market buy and sale of Edgewise Therapeutics, Inc. stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are only selling over the last 12 months: $0 bought and $17.6M sold.
Buying and selling by month
open market, last 12 monthsGet an alert when EWTX insiders trade
We read every Form 4 the moment the SEC posts it and tell you when an EWTX officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.
Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.
Every EWTX insider trade
2 years · newest first| Insider | Type | Price | Held after | Filed | |||
|---|---|---|---|---|---|---|---|
| Nov 16, 2026 | Joanne M. DonovanCmo | Sale plan | 854 | $45.48 | $39K | 8,139 | Nov 18Form 4 |
| Nov 10, 2026 | Michael NofiCFO | Sale | 4,442 | $45.43 | $202K | 6,495 | Nov 10Form 4 |
| Aug 13, 2026 | Joanne M. DonovanCmo | Sale | 9,441 | $43.71 | $413K | 8,625 | Aug 14Form 4 |
| Aug 12, 2026 | Kevin KochPresident and CEO | Sale | 17,971 | $43.68 | $785K | 52,488 | Aug 14Form 4 |
| Aug 12, 2026 | John R MooreGeneral Counsel | Sale | 5,016 | $43.82 | $220K | 17,697 | Aug 14Form 4 |
| Aug 12, 2026 | Behrad DerakhshanChief Business Officer | Sale | 5,100 | $43.81 | $223K | 31,826 | Aug 14Form 4 |
| Aug 12, 2026 | Alan J RussellChief Scientific Officer | Sale | 5,901 | $43.73 | $258K | 31,466 | Aug 14Form 4 |
| Jul 1, 2026 | Alan J RussellChief Scientific Officer | Sale plan | 200,000 | $39.41 | $7.9M | 24,555 | Jul 2Form 4 |
| May 5, 2026 | Joanne M. DonovanCmo | Sale | 55,230 | $37.88 | $2.1M | 4,367 | May 5Form 4 |
| Apr 1, 2026 | Joanne M. DonovanCmo | Sale plan | 28,662 | $32.31 | $926K | 9,597 | Apr 2Form 4 |
| Mar 31, 2026 | Joanne M. DonovanCmo | Sale plan | 21,338 | $32.12 | $685K | 9,597 | Mar 31Form 4 |
| Mar 27, 2026 | Joanne M. DonovanCmo | Sale plan | 16,358 | $30.98 | $507K | 9,597 | Mar 30Form 4 |
| Jan 21, 2026 | Badreddin EdrisDirector | Sale plan | 115,471 | $29.44 | $3.4M | 19,820 | Jan 23Form 4 |
| Nov 12, 2025 | Alan J RussellChief Scientific Officer | Sale | 100,000 | $21.12 | $2.1M | 23,400 | Nov 13Form 4 |
| Nov 11, 2025 | Jonathan C FoxDirector | Buy | 10,700 | $18.64 | $199K | 23,702 | Nov 13Form 4 |
EWTX insider trading FAQ
Are EWTX insiders buying or selling?
Insiders are only selling over the last 12 months. 0 insiders bought $0 of EWTX on the open market in 0 trades, and 7 sold $17.6M in 13 trades, 76% of that under pre-arranged trading plans.
When did an EWTX insider last buy shares?
Jonathan C Fox (Director) bought 10,700 shares for $199K on Nov 11, 2025, reported on Nov 13, 2025.
When did an EWTX insider last sell shares?
Joanne M. Donovan (Cmo) sold 854 shares for $39K on Nov 16, 2026, under a pre-arranged trading plan.
What is a Form 4?
Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.
Why do insider sales matter less than buys?
Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.
From SEC Form 4 filings · Not investment advice
